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ABSTRACT
Polyphosphate kinase may have a role in regulating the physiology of cells living in less than optimal
conditions such as those facing bacteria in stationary and death phases. Experimental studies were
performed to assess the role of polyphosphate kinase on the long term survival of Helicobacter pylori. I
created isogenic mutant strains deficient in the production of polyphosphate kinase by targeted insertional
mutagenesis using a kanamycin resistance cassette and collected strains from other laboratories.
Bacteria were grown to stationary phase, and then plated periodically to measure the decline in culturability.
My mutants showed a decrease in colony forming unit survival after 10 days compared with their parent
strain. However, a second isogenic pair constructed with a chloramphenicol resistance cassette did not
show a decrease. My results are therefore equivocal.
Thesis Supervisor: David Schauer
Title: Associate Professor of Toxicology
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Introduction
Polyphosphate and long term survival
Polyphosphate (PP) is a long chain polymer of phosphates that has been detected in every natural
living cell (Akiyama, Crooke, and Kornberg 1992; Bode et. al., 1993). A few enzymes are known to
process PP. Polyphosphate kinase (PPK) catalyses the reversible polymerization of PP from adenosine
triphosphate (ATP). The physiological role of PP is not known. Because levels of PP change dramatically
as cultures reach stationary and death phase, it has been suggested that PP plays a role in long term survival
(Ault-Riche et.al., 1998; Kim et.al., 1998).
Although PP can drive the production of ATP, energy calculations show that it can not serve as a
long term energy storage media because it could only power a cell for a matter of seconds. It is much more
likely to serve a regulatory purpose (Blum et.al., 1997; Kumble, Ahn, and Kornberg 1996). PP
concentration versus growth phase profiles have been measured for a variety of species. Some bacterial
species have high levels of PP just before the end of the exponential growth period and very low levels after
a short time in stationary phase. Other bacterial species only begin to accumulate PP after reaching
stationary phase. Because there is considerable variation in the dynamics of PP accumulation among
bacterial species the gene regulation framework is likely not well conserved.
The Viable But Not Cultured (VBNC) hypothesis
When faced with adverse conditions some gram negative bacteria, such as many Vibrio species,
can enter a physiological state in which they do not grow on conventional media which normally supports
growth(Barer 1997; Dixon 1998; Whitesides and Oliver 1997; Byrd, Xu, and Colwell 1991). However, the
bacterial cells remain viable as measured by such techniques as differential single stranded versus double
stranded DNA staining, and detection of active electron transport systems by the reduction of a colorless
substrate, 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride (INT), to form a visible
precipitate. Cultures with no cells capable of forming colonies on standard media can in some cases cause
infection and disease in susceptible experimental animals, allowing recovery of normally culturable
bacteria. (Cellini et.al., 1994[1])
There are no general rules concerning nutrient concentration, temperature, and osmotic stress
which apply to the recovery of all species. In some cases, the optimal conditions for induction of a VBNC
state and subsequent recovery to fully culturable cells have been discovered (Whitesides and Oliver 1997).
The VBNC hypothesis is not universally accepted (Bogosian, Morris, and O'Neil 1998; Kusters et.al.,
1997).
Helicobacter pylori
Helicobacter pylori is a gram negative microaerobic spiral shaped bacterium which undergoes a
morphological change to a spherical coccoid form under such stresses as nutrient deprivation and sub-lethal
antimicrobial insult (Bode, Mauch, and Malfertheiner 1993; Cellini et.al., 1994[2]; Benaissa et.al., 1996).
It is the etiologic agent of peptic ulcer disease. Life-long infection is linked with an elevated risk of cancer
in the stomach. H. pylori has been found in gastric biopsies, feces, and dental plaque of humans (Nguyen
et.al., 1993). Although humans mount an immune response to H. pylori, the infection is usually not cleared,
resulting in a life-long chronic infection. Few of those infected show any clinical signs of gastritis, despite
clear evidence by histology.
In the developing nations, most people are infected before age twenty and the direct fecal-oral
route of transmission is generally considered to be most important. The rate of infection in adults in the
developed nations is about 1 percent per year. This is consistent with both the direct oral-oral route and the
indirect via surface waters route of transmission (Lee, Fox, and Hazell 1993; Chuanfu et.al., 1996).
Epidemiologic studies in Peru suggest that drinking municipal water, instead of drinking private well water,
increases the risk for H. pylori infection.
Transmission of H. pylori via environmental waters has not been clearly demonstrated. Efforts to
culture the organism from the environment have failed. However, PCR studies have shown the presence of
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H. pylori DNA at locations which if the organism were to be cultured, a threat to public health would be
clearly recognized (Hulten et.al., 1996; Hulten et.al., 1998). While a VBNC form of H. pylori is consistent
with the available data on human infection patterns, the evidence for the existence of H. pylori in a VBNC
state is not as robust as that for other organisms (Cellini et.al., 1994[1]; Eaton et.al., 1995; Cellini 1996;
Eaton et.al., 1996; Wang et.al., 1997). The debate is further clouded by the spiral to coccoid morphological
transformation which may or may not have any relevance to a death resistant or VBNC state.
My studies seek an understanding of the parameters which govern the loss of culturability. Such
understanding is needed to design experiments to more definitively assess the possible existence of a VBNC
state in H. pylori. The primary factor under investigation is the presence or absence of a functional PPK
gene.
Preliminary survival studies were performed with the ATCC type strain and an isogenic mutant in
which the PPK gene was inactivated by insertion of a kanamycin resistance cassette (aphA-3). In an
attempt to control for any effect on survival of the antibiotic resistance marker, a second pair of H. pylori
strains consisting of N6 and its isogenic urease (ureBAaphA-3) knockout were included (Ferrero et all,
1992). Each of the kanamycin resistant mutants was significantly impaired in long term survival. The
relative difference between the two pairs was small. Urease catalyzes the hydrolysis of urea to form
ammonia and carbon dioxide with an accompanying rise in pH. In the growth and storage conditions used,
virtually no urea was present. In the absence of urea, urease is expected to play no biochemical role,
although a role in membrane structure can not be ruled out. Therefore, the kanamycin resistance cassette
may be responsible for most or all of the reduced long term survival of those mutants. I also use a PPK
deletion mutant with a chloramphenicol marker, courtesy of Timothy McDaniels. Because a set of isogenic
mutants in a single strain background with the proper controls was not assembled my results are equivocal.
Materials and Methods
Culture Conditions
E. coli DH5-x was grown in LB or on LBA at 370 C.
The H. pylori strains were grown out of permanent stock on Tryptic Soy Agar (TSA) supplemented with
5% defibronated sheep blood in a 5% C0 2 incubator at 37 0 C. A single colony of each strain was subcultured
on a fresh plate. In the first two survival studies, H. pylori strains were grown in a single 24 hour passage in
the optimal broth (OB) of Andersen et.al. [ref] modified by using defibronated sheep blood instead of
citrated human blood.
DNA analyses
Restriction endonuclease digestions and other common DNA manipulations were performed by standard
procedures as recommended by the manufacturer. Enzymes and DNA ladders were purchased from New
England Biolabs. DNA fragments were separated by electrophoresis in horizontal slab gels containing 1%
agarose and run in Tris-acetate buffer. DNA was visualized with ethidium bromide.
PCR conditions
Amplification reactions were carried out on total DNA extracted from H. pylori in a Perkin Elmer thermal
cycler by using a pair of oligonucleotides that match regions near the end of the PPK gene. The predicted
product is 1890 base pairs and contains a BglII site at the midpoint. Primer IF is a 24mer: CGA AGC CAA
AGA TGA GAG CTT GCC. Primer RIW is a 24mer: GCC TTT AGA ATT TAA CTC GTA GCG.
Reactions were cycled 25 times; 94'C 1 minute, 52'C 55 seconds, 72'C for 2 minutes plus 7 seconds each
cycle.
Insertional Mutagenesis
The PPK PCR product was ligated into pGEM-T-easy, and used to transform E. coli DH5-u .
Transformants were selected for grown on ampicillin, and disruption of lac-Z, producing white colonies on
IPTG and x-gal. Replicate plasmids were harvested (pJWIHOO1, pJWH002, pJWHO03, pJWH005,
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pJWHO06), and cut with EcoRI to confirm the insert size. Plasmid pJWHOO1 was chosen and cut with
BglII in the middle of the PPK insert.
The kanamycin resistance cassette was taken from pILL600 (Labigne, Courcoux, and Tompkins 1992;
Labigne-Roussel, Courcoux, and Tompkins 1988)) by cutting with BamHI to release the Kan' fragment with
cohesive ends compatible with the BglII cut site in PPK. The remaining pBR322 backbone would have
been split into two compatible BamHI fragments. Possible ligation products would have included a
functional beta-lactamase conferring resistance to ampicillin. Therefore a double digest with HincII was
performed to produce blunt end cuts in both the beta-lactamase and the tetracycline resistance genes in the
pBR322 backbone. After complete digestion with both enzymes the only possible ligation product
conferring resistance to both ampicillin and kanamycin was the desired insertion of the kanamycin
resistance cassette into the PPK gene.
The BamHI and BglII ends were ligated and the resulting plasmid was used to transform E. coli DH5-o and
selected on ampicillin and kanamycin. Four colonies were picked and replicate plasmids were harvested
(pJWH007, pJWH008, pJWH0O09, pJWHO10). The plasmid pJWH008 was used to transform H. pylori.
Transformation of H. pylori
Three plates of H. pylori type strain (ATCC 43504) were resuspended and washed in ice cold 15% glycerol
7% sucrose wash buffer, in 1 mL, imL, 0.5 mL, and resuspended in 0.08 mL and split into 2 prechilled
electroporation cuvettes. 40 mL of cells and 2.5 mL plasmid DNA were incubated for 10 minutes on ice,
then electroporated at 2.5 kV. Time constants were 5.6 for the first cuvette and 1.9 for the second cuvette.
The cells were incubated a further 10 minutes on ice, then plated and grown for two days on TSA plus 5%
defibronated sheep blood. All outgrowth was resuspended in 100 mL SOC and a loopfull was streaked in
triplicate onto plates containing kanamycin. Two days later, several pinpoint colonies from the kanamycin
plates were streaked onto fresh kanamycin plates. Five days later two colonies were chosen (JWHO0 1,
JWHO02), grown without kanamycin and frozen at -80C in brucella broth with 20% glycerol. The mutant
construction was verified with PCR (Figure 1.) using the same primers and conditions used for cloning.
Biochemical characterization was performed with the assistance of the Arthur Kornberg lab, Stanford
Universit School of Medicine, as detailed in appendix 1.
Figure 1. PCR verification of isogenic PPK mutant construction. PCR was performed on genomic DNA.
Lanes 1 and 5: 1 kb DNA ladder. Lane 2: type strain. Lane 3: JWH001. Lane 4: JWH002.
Storage and CFU Survival, experiment 1
The H. pylori type strain and the JWH002 derivative were grown overnight in 10 mL OB stirred in a 25 mL
flask. The cultures were diluted by mixing 0.4 mL culture and 3.6 mL distilled water into a 5 mL snap cap
tube and placed at 40C. At 0, 5, 9, 19, 24, and 30 days, serial dilutions in phosphate buffered saline (PBS)
were plated by spreading 0.1 mL samples onto TSA + 5% defibronated sheep blood. Plates were placed
inside anaerobic jars. The jars were twice evacuated to 80 kPA and filled with 10% H2, 10% CO 2 , and
80% N2. The jars were placed inside a 37*C incubator. Colonies were counted after 3 to 5 days growth.
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Storage and CFU Survival, experiment 2
The H. pylori N6 strain, and its derivative ureB mutant N6::ureBAKan (courtesy of Jay Solnick; Ferrero et
all, 1992), constructed with the same kanamycin resistance cassette from pILL600 were used to control for
the survival effects of the kanamycin resistance gene. The H. pylori type strain, its JWH001 derivative, the
H. pylori N6 strain, and its N6::ureBAKan derivative were grown overnight unstirred in 10 mL OB in a
culture tube. The upper 8.5 mL of culture was harvested and the cells were pelleted. The supernatant was
carefully removed and 1 mL was mixed with 9 mL distilled water. 3 mL of diluted supernatant was used to
resuspend the cell pellets. 1 mL aliquots were placed in 1.5 mL conical snap top centrifuge tubes, briefly
centrifuged and placed at 4'C. At 0, 2, and 5 days, samples were withdrawn, vortexed for 10s, and serial
dilutions in PBS were plated by spreading 0.1 mL samples onto TSA + 5% defibronated sheep blood.
Plates were placed in a 5% C0 2 incubator at 37'C. Colonies were counted after 4 or 5 days. Colonies were
counted after 4 or 5 days.
Storage and CFU Survival, experiment 3
The H. pylori G27 strain, and its derivative PPK mutant G27:PPKACam (courtesy of Timothy McDaniels)
were harvested from one day old plates with a plastic scraper and placed in 50 mL Tryptic Soy Broth
(TSB) supplemented with 5% heat inactivated calf serum in a 250 mL culture flask with a magnetic stir bar.
The flasks were placed inside anaerobic jars. The jars were twice evacuated to 80 kPA and filled with 10%
H2, 10% C0 2 , and 80% N2 . The assemblies were placed on a multi-channel stir plate inside a 37'C
incubator. After 5 days of growth 10 mL of culture was removed and added to fresh media and the new
flasks were assembled gassed and incubated as before. After 3 days of secondary broth growth, 1 mL
aliquots were placed in 1.5 mL conical snap top centrifuge tubes, briefly centrifuged and placed at 4'C .
At 0, 3, 5, 6, 11, 12, and 18 days, samples were withdrawn, vortexed for 10s, and serial dilutions in PBS
were plated by drip spreading 0.1 mL samples onto TSA + 5% defibronated sheep blood. Plates were set in
a 5% C0 2 incubator at 37'C. Colonies were counted after 3 to 5 days growth.
Results
PP and PPK Biochemical assays results
Compared to wild type JWHOO1 showed a less than 20% reduction in accumulated PP levels. PPK
activity was uniformly very low, less than 250 picomol/mg/minute. Background radiation was 204 cpm,
while the highest sample was only 549 cpm. Therefore, the signal was barely above twice the background
noise and the assay should be repeated with a higher specific radioactivity.
The activity results agree generally with those of the Kornberg lab on other Helicobacter strains.
They also found very low specific activities despite large accumulations of PP. The mutant strain used in
experiment 3 when assayed by the Kornberg lab showed a -99% reduction in accumulated PP (Cresson
Fraley, personal communication).
Storage and CFU Survival, experiment 1 results
Experiment 1 measured the long term CFU survival of the type strain of H. pylori and my isogenic
PPK mutant constructed with a kanamycin resistance marker. The mutant did not survive as well as the
wild type. Starting with concentrations of a little more than 108 CFU/mL, both strains survived for at least
24 days. The death curve was nearly exponential. Between 9 and 24 days the PPK mutant lost culturability
more quickly. At 24 days the overall fraction surviving was about 60 times higher in the wild type than the
mutant, suggesting that PPK was involved in long term survival.
However, the effect measured in experiment 1 could also have been caused by the kanamycin
resistance marker. The resistance is achieved with a membrane spanning pump which removes kanamycin
molecules from the cell. This may disrupt the normal membrane enough to cause the cells to die more
quickly in death phase. Because this experiment lacked any control for the kanamycin marker, the results
were not conclusive.
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Storage and CFU Survival, experiment 2 results
Experiment 2 measured the long term CFU survival of 4 strains of H. pylori : 1) the type strain, 2)
its isogenic PPKAaphA-3 mutant, 3) the N6 strain, and 4) its isogenic ureBAaphA-3 mutant. The strains
were chosen based on the assumption that under the tested conditions urease activity has no effect on long
term survival. Any difference between the two N6 strains should be ascribed to the kanamycin resistance
marker. A comparison of the differences within each pair of strains would reveal the extent to which the
difference in survival in the PPK pair was due to the disruption of the PPK gene and the extent to which it
was due to the kanamycin resistance marker.
The starting concentration in experiment 2 was around 106 CFU/mL. All the cells died rapidly,
with no CFUs surviving beyond 5 days. In this brief time, the PPK pair lost culturability at about the same
rate. However within the ureB pair the mutant died more quickly than the wild type. Experiment 2 did not
achieve a high enough cell density nor did it prolong CFU survival long enough to be compared with the
other experiments. Furthermore, the small number of time points sampled makes this experiment
unhelpful.
Storage and CFU Survival, experiment 3 results
Experiment 3 measured the long term CFU survival of the G27 strain of H. pylori and an isogenic
PPK mutant constructed with a chloramphenicol resistance marker. The mutant survived as well as the wild
type. Starting with concentrations of a little more than 108 and 109 CFU/mL, both strains survived for 5
days with almost no deaths. The death curve was not exponential. Between 5 and 11 days both strains lost
culturability quickly. The overall shape of the death curves was the same, suggesting that PPK was not
involved in long term survival.
Experiment 3 used a chloramphenicol marker and showed no difference in the rate of loss of
culturability between wild type and a strain which makes less than 1% (Cresson Fraley, personal
communication) of the wild type level of PP. However, the starting CFU concentration was 10 fold
different. I conclude therefore that I have not demonstrated a role for polyphosphate in the long term
survival of Helicobacter pylori.
Discussion
The results of my experiments were equivocal. In order to conclusively determine that PPK does
not play a role in long term survival of H. pylori, a different set of experiments must be performed. If an
unmarked deletion of the PPK gene could be constructed, there would be no need for an extra strain to
control for the effect of the antibiotic resistance gene. Otherwise, a set of isogenic mutants must be created
from a single parent H. pylori strain, in which the antibiotic resistance marker has been inserted into the
PPK gene in one mutant and in other mutants into a few other places where it either doesn't interrupt a gene
or interrupts a gene known to have no role in long term survival.
Furthermore, the experiments should be repeated several times under the same conditions, with
more replicate samples plated at each time point. If these conditions can be met, a role for PPK in the long
term survival of H. pylori can be definitively disproved or proven.
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Result data in table and graph form
Day Exp 1 Exp 1 Exp 2 Exp 2 Exp 2 Exp 2 Exp 3 Exp 3
Type Type: Type Type: N6 N6: G27 G27:
PPK/Kan PPK/Kan ureB/Kan PPK/Cam
0 3.1E8 2.0E8 7.0E5 1.1E5 2.7E5 1.9E6 1.1E9 2.0E8
2 1.0E3 3.0E1 9.1E3 8.0E1
3 8.0E8 1.5E8
5 1.3E7 5.0E6 6.0E1 3.2E8 2.7E7
6 1.6E8 2.4E6
9 5.0E6 1.4E6
11 1.0 E 3 9.0 E 0
12 3.3 E 2
18 9.0 E 0
19 1.4 E 5 1.7 E 3
24 2.5 E 4 2.5 E 2
30 4.4 E 3
Table 1. Colony forming units per mL
Survival of H. pylorn CFU at 4 degrees C
1.OE+10 - --- ------- --- ---------.. ....------
--- (Exp. 1) Type
1.OE+09 
-- w-- -(Exp. 1) JWH002
- (Exp. 2) Type
1.OE+08 -a-.. -5--- (Exp. 2) JWH001
-- U -(Exp. 2) N6
1.OE+07 --- -(Exp. 2) N6::ureBAKan
-- .- .(Exp.3)G27
1.OE+06 - -- U - - .- * - - ---- (Exp. 3) G27:PPKACam
0 1.OE+05 ' -
1.OE+04
1.OE+03 
- -gill
1.OE+02
1.OE+01A
0 5 10 15 20 25 30
Days
Figure 2. The decline in culturability is shown as colony forming units per mL at each sampling time. Data
points in experiment 1 represents a single sampling. Data points in experiments 2 and 3 represent the mean
of three independent samplings. The final points on experiment 3 were below the limit of detection (10
CFU/mL).
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Appendix 1
Polyphosphate biochemical assays
These assays were developed in the Arthur Kornberg lab, Department of Biochemistry, Stanford University
School of Medicine, Stanford California. These assays were performed in their lab with their gracious help.
The assays were performed on plate grown bacteria, not broth grown cultures. This is known to be
problematic because the cells are in different growth phases.
Glass Milk Polyphosphate Extraction from Cells
10 cell lysis: Cell pellet + 300 microliters 4 M GITC, 50 mM Tris. Resuspend. Incubate 3
minutes at 95'C. Vortex for 5 seconds at 1 minute and at the end.
Protein denaturation: Add 30 microliters 10% SDS. Incubate 2 minutes at 95'C. Should be
clear.
PolyP binding: Add 5 microliters glass-milk, 300 microliters 50% ethanol. Vortex 5 seconds.
Incubate 30 seconds at 95 0C .
Debris discard: Centrifuge 1 minute 1,200 RPM. May have jelly on top. Discard supernatant.
1st wash: Add 200 microliters ice cold wash buffer (50 mM NaCl, 5 mM Tris, 5 mM EDTA and
50% ethanol). Vortex 5 seconds, it may be hard to suspend. Centrifuge 30 seconds 1,200 RPM. Discard
supernatant.
N. A. digestion: Add 100 microliters digestion mixture ( 5ug/mL DNAse/ RNAse, 50 mM Tris-
HC1 pH 7.0 and 5 mM Mg . Pipette up and down. Incubate 30 minutes 37'C .
2nd wash: Add 200 microliters ice cold wash buffer (50 mM NaCl, 5 mM Tris, 5 mM EDTA and
50% ethanol). Vortex 5 seconds, it should be easy to suspend. Centrifuge 30 seconds 1,200 RPM. Discard
supernatant.
3rd wash: Add 200 microliters ice cold wash buffer (50 mM NaCl, 5 mM Tris, 5 mM EDTA and
50% ethanol). Vortex 5 seconds, it should be easy to suspend. Centrifuge 30 seconds 1,200 RPM. Discard
supernatant.
1st polyP extraction: Add 100 microliters dH 20. Vortex briefly. Incubate 30 seconds 95'C .
Vortex briefly. Centrifuge 1 minute 1,200 RPM. Save supernatant.
2nd polyP extraction: Add 100 microliters dH 20. Vortex briefly. Incubate 30 seconds 95'C .
Vortex briefly. Centrifuge 1 minute 1,200 RPM. Save supernatant, pool with 1" extraction.
PolyP storage: at -20'C .
Polyphosphate Detection
ATP production: Mix a reaction tube with 10 microliters of polyP sample and final
concentrations: 50 mM HEPES-KOH (pH 7.2), 40 mM ammonium sulfate, 4 mM MgCl 2, 0.1 mM ADP,
10-50 ng PPK. Incubate 40 minutes 37C . Stop the reaction by adding 5 mM EDTA, 50 mM Tris total.
ATP detection: According to the luciferase kit manufacturer's directions.
Polyphosphate Kinase Activity Sample Preparation
A cell pellet equivalent to 1 mL culture is suspended in 1 mL Tris-HCl buffer (50 mM pH7.5)
containing 10% sucrose. Freeze in liquid nitrogen and store at -80'C if not used immediately.
To cell suspension add 2mM fresh dithiothreitol and 250 microgram/mL lysozyme. Incubate at
00 C for 30 minutes. Lyse cells for 4 minutes in a 37'C water bath, followed by immediate chilling in an
ice bath. Sonicate in an ice bath for 30 seconds. Centrifuge 5 minutes at 5000 RPM at 4'C in a microfuge.
Discard the pellet, which contains unbroken cells and cell wall fragments. Centrifuge the low speed
11
supernatant in a table-top Beckman ultra centrifuge 100.2 rotor for 10 minutes at 95,000 RPM (or 30
minutes at 50,000 RPM) at 4-C . Save both the pellet and the supernatant.
To the pellet add 100 microliters tris-HCl buffer (pH7.5; 50 mM containing 10% sucrose; 5 mM
MgCl2, and 10 microgram/mL each of DNAse I and RNAse A) and sonicate in an ice bath 3x30 seconds,
carefully mixing without vortexing. This is the membrane preparation. Both the membrane preparation and
the high speed supernatant can be tested for polyphosphate kinase and exopolyphosphatase I activity.
Polyphosphate Kinase Activity Assay
The assay measures the formation of the acid-insoluble [32P, polyphosphate by the polymerization
of the terminal phosphate [gamma- P] of ATP.
Reaction Mixture: hepes-KOH buffer pH 7.2 50 mM, ammonium sulfate 40 mM, MgCl2 4mM,
[gamma- 32P] ATP (2000 cpm/nmol) 1mM, creatine phosphate 2mM, creatine kinase 20 micrograms/mL, in
a total volume with the samle of 250 microliters.
PPK is added after the reaction mix is equilibrated to 37'C . Control tubes are set up with heat
inactivated enzyme and/or with enzyme buffer.
After incubation, the reaction is stopped by the addition of 250 microliters of 7% HClO 4 and 50
microliters of 2 mg/mL bovine serum albumin. Place the tubes on ice until the contents are filtered. Filter
the mixture on presoaked (in washing solution) Whatman GF/C glass fiber filters using vacuum. Wash 3
times with 10 mL (each time) washing solution (0.1 M sodium pyrophosphate made in 1 M HCl) followed
by washing 3 times with 10 mL of ehanol (100%), each time. Dry the filters and the [32 P]polyP collected on
the filters is measured in a liquid scintillation counter. Use 4 mL of the Ready safe scintillation cocktail per
filter. Reaction mix can be made at 5X concentration. When a much higher specific activity of ATP (e.g.
104 cpm/pmol) is required, excess unlabeled ATP is added after acidification, and the product is washed
using a large volume of washing solution to reduce the background (ca. 300 cmp). An ATP regenerating
system is used in the assay because of the inhibitory effect of ADP.
Effect of enzyme (protein) concentration: Include various amounts of enzyme based on protein
concentration (2-50 micrograms per tube in crude extracts) and by dilution of the enzyme preparation into
the reaction mix and incubate for a specific period of time (e.g. 15 minutes) and determine the enzyme
activity. Plot activity -vs- protein concentration.
Time course of enzyme reaction: Incubate the reaction mix with a known amount of enzyme,
remove aliquots at 0, 5, 10, 15, 20, 30, and 60 minute time intervals and stop reaction by pipetting into 250
microliters of HClO 4 (7%). Add 50 microliters of 2 mg/mL BSA, filter and count. Plot activity -vs- time.
Specific activity: One unit of enzyme is defined as the amount incorporating 1 pmol of phosphate
into acid-insoluble polyP per minute.
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Appendix 2
16s rRNA Primers for Helicobacter detection, differentiation, and
quantitation.
The published 16s rRNA sequences for several Helicobacter species and the E. coli universal
sequence were aligned. The 66% consensus sequence was constructed. Primer sites suitable for H. pylori
specific, and Helicobacter genus specific amplification were identified. The primers were extended on the
5' end so as to bring all the predicted melting temperatures close to 60'C
16s pyai 787F Primr G T T GT TG GAG GG CT T AG T CT CC
U00006 E. i rrsB (ive sd) GA CT ... ... ... TG. GA GG .TT GTG CC ... ... CTT GA ... ... ... ... ... ... ... ... ... ... .. GGC GT GGC TT CCG
m88157 H.pylai (1) TG CT . AG. T T .G .TG GAG .GG ... ... CTT .AG ... ... ... . ... ... ... ... ... ... ... TCT CT CCA GT AAT
U00679 H.1cri (2) .TG CT . AG. TT .GT .TG GAG GG .. CTT .AG .. ... ... ... ... ... ... ... ... ... .. TCT CT CCA GT AATZ25741 H.pylcri (3) .IG CT . AG. TT .GT .TG GAG .GG .. CT T .AG .... ... ... ... ... ... ... ... ... ... TCT CT CCA .GT AAT
M55303 H.pyiai (4) ... ... ... .
X67854 H.namtrinco .G CT ... . AG. TT .GT .TG GAG .GG .. CT T .AG ... ... ... ... ... ....... ... ... ... TC .CT CCA .GT AAT
M437643 H.dis .TG CT ... ... ... MG. TT .GT .G GGG . ... ... CTT .GT ... ... ... ... ... ... ... ... ... ... ... CCT .C. CCA .GT AAT
u51872 H.fdis .TG CT . ... ... AG. TI .GT G GGG GG CTT TGT ... ... ... ... ... .1. .. ... ... ... ... CCT .C. CCA .GT AAT
L13464 H.ncrs .TG CT . AG. T GT .1G CCC .G CTT GT ... ... ... ... ... ... ... ... .. ... ... CAG .G. GCA GT AAT
M8150 H.dncad .TG CT . NG. IT .GT .TG CCC .G .. CT T T .. ... ... I.. ... ... ... .... CAG .G. GCA .GT AATU46129 H.cdeTus .G CT . AG. T TGT .G GGG . .. CTT .GT ... ... ... ... ... ... ... ... ... ... ... CAC .T. CCA .GT AAT
Y09405 H.sdcnos .1G .CT . AG. TT GT TG GGG GG CT T TG ... ... ... ... ... ... .. ..... ... ... TCC .CC CCA .GT AAT
X81028 H."mdrnz" .G CT ... ... ... AG. TT .GT .G CCC .G . . CT T .GT ... . ... ... ... ... ... ... ... ... ... CAG .G. GCA .GT AAT
L12765"F.rcppin" .TG AT ... ... ... AG. TT .GT G CCC .G .. ... T GT ... ... ... ... ... ... ... ... ... ... ... CAG .G. GCA .GT AAT
LXX) H.lis (VSremc d .0TG CT . AG. TT .GT .G CCC TG CTT GT ... ... ... ... ... ... ... ... ... ... ... GAG .G. GCA .GT AAT136141 H.pLlaum .TG CT . AG. TT GT .G TGA GG CTT GT ... ... ... ... ... ... ... ... ... ... ... CT .T. GCA .GT AAT
u65103 H.trogntum .G CT ... ... . AG. TT .GT .1G CCC .G . . CT T GT ... ... ... ... ... ... ... ... ... ... ... CAG .G. GCA .GT AAT
u07574 H.heciks .1G CT AG. TT .GT .1G CCT G ... ... CTT .GT ... ... ... ... ... ... ... ... ... ... ... GAG .G. GCA .GT AAT
AF058768 H.hlm 6c i .G CT . AG. TT .GT G GGG GG ... ... CTT TGT ... ... ... ... ... ... ... ... ... ... CCT .C. CCA .GT AAT
M0205 H.muridxum .G CT . AG. TT .GT .1G CCT TG ... ... CTT .GA ... ... ... ... ... ... ... ... ... ... ... CAG .G. GCA .GT AAT
M88147 H.pcinetesis .TG CT . AG. T T .G T. GTG G.A G.. CT T.G T..... ... ... ... ... ... ... ... ... ... .CT C.T GC AG TAAU96296 H.roantium .TG CT . AG. T T .GT .G CGA .GG .. CT T GT .. ... ... ... .. ... ... ... ... ... ... CCT .T. GCA .GT AAT
W5048 H.rmstdo .TG CT . AG. TT GT .G GGG G ... CT T GT ... ... ... ... ... ... ... ... ... ... ... CAC T. CCA .GT AATABD6148 H.suna .TG CT . AG. TT .GT TG GGG G CTT ..G ... ... ... ... ... ... ... .10 .. ... ... TCA CT CCA .GT AAT
M88159 WdindlaSucincenes .G CT . AG. TT .GT .G CCC G CTT GT ... ... ... ... ... ... ... ... ... ... ... CAG .GG CAG TA ATG66% Hdio bcd rs Ccnensus .G CT ... ... ... AG. TT .GT .1G BVN DG ... ... CTT GT ... ... ... ... ... ... ... ... .. ... ... CHB .B. SCA .GT AAT
U00006 E.03i rrs8 (urvesd) TG .. - .. CC T . COG ..G G.. P..AA CCG TG .AG A. ... C A. GGT GC TGC ATG GC
m88157 H.pori (1) TG .I.... TC T A GC IT . .. GC TAG AC CT T .G A AAA CA GGT GCT G.CU00679 Hpori (2) TG .TC I G ..GC TT GC CAG AC CT T G A AAA CA GGT GCT G.CZ25741 H.pNri (3) TG TC T A GC TT GC TAG AC CT T.. G A, AAA CA GGT GCT G.CV55303 H.pl (4) 
..
X67854H.nemestrInc TG. TC I G . GC . TT ... AC TAA AT CC T G A AAA CA GGT C GCW7643 H fTis TG. .. I.-TC .. A . -. GC IT GC TAG AC CC T . A AAA CA GGT GCT G.C
u51872 HelIs TG. . TC .. A . ..GC .T GC TAG AC CC T G A AA CA GGT GCT G.CL 13464 H.crls TG . ..... TC . A. ...GC TT .. GC TAG AC CT T .G A AAA CA GGT GCT G.C38150 HdnodT . CT G. .GC TT ...... GC CAG AG CT T .. ... G A . AAA CA GGT GCT N.CU46129 H.cdecys ICs TG. .C .. G GC T ....... GC CAG AG CT T .. A AAA CA GGT GCT GCY09405 H.sdancNs TG .. I.-TC .T A. . .GC T T GC TAG AC CC T. G A. AAA CA GGT GCT G.CX81028 H.mdnz" T G C .T G.. .... GT T GC CAG AG CT T G A, AAA CA GGT GCT G.CL12765"F.rqprn" TG ..C T G.. GC TT .... GC CAG AG CT T G A. AAA CA GGT GCT G.C(XX) H tls (VS remcec) TG. -C .T G.. GC TT ..... GC CAG AG C T . G A. ANACA GGT GCT G.C136141 H.pUlcrLm TG. .... C .1 G. . . GC TT ... GC CAG AG CT T.. .. . G A. AAA CA GGT GCT G.C
u65103 H.trogcn TG ....C . .CC TT C-C 0 .. A C. A AA CA GGT GCT G.C
us7574 H.hepacus T G C . .C IT OG .GGG AG CT T A AAA CA GGT GCT GCAF058768 H.helmonrii TG TC . A . .GC TT GC TAG AC CC T.. G A AAA CA GGT GCT G.CM50205 H muridnm TG CC .A C.. .... . TT -. CT GTG GAG.CT T G A. AAA CA GGT GCT G.CN48147 Hpxneteris TG .C . G.. GC TT .... GC CAG AG CT T.. .. G A. AAA CA GGT GCT G.CU96296H rodnrn TG .... C . A . GC TT ....... GC TAG AA CT T G A. AAA .CA GGT GCT G.C
T5048HKmustdo G ... TC . A . GT ... TT AC TAG AC CT T G A. AAA CA GGT GCT GCAB006148 H.sLncus TG TC .T A, .C.GT TT .AC TAG AC CT T .. .C. .... . .. A. AAA CA GGT GCT GC8159WdIndIaSuncges TG CC .G G. T .00TGG AG CT T . _G A. AAA CA GGT GCT GC66% HeacrbxCtes Ccn-ss TG. .YC T V.. GC ... TT GC BAG AN CT T G A. AAA CA GGT GCT GC
16s p)ai 1017R Prime <- 3' A T CG AA COG AT C TG GA A C T TTT GT CCA 5'
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U00006 E.cdI rrsB (unvrsd) .J C.C CT. AG. C.T GG TC T.. G.A GA. GGA T..
m88157 H.pylai (1) .C G.G GT. AT C.C G.G .C T.. GA GA GGG T..
U00679 H.pylai (2) .C G.G GT, AT. C.C G.G .CC T.. G.A GA. GGG T..
Z25741H.pplai(3) .C G.G GT. AT, C.C G.G .C T., G.A GA GGG T..
M/55303 Hpylai (4) .C G.G GT. AT. C.C G.G .C T.. G.A GA. GGG T..
X67854 H.naTmino .C G.G GT. AT. C.C G.G CC T.. G.A GA. GGG T.
7643H.fdlis C G.G GT AT. C.C G.G .CC T., GA GA GGG T..
u51872H.fdis C G.G GT. AT. C.C G.G .C T.. GA GA. GGG T..
L1344H6ns C G.G GT. AT. C.C G.G .CC T.. GA GA. GGG T..
Tf8150 H.ancd C G.G GT. AT. C.C G.G .CC T.. GA GA GGG T.,
U46129 H.chdecys tus C G.G GT. AT, CC G.G .C T.. G.A GA. GGG T.,
Y09405 Hsd ms C G.G GT. AT. C.C G.G .C T.. G.A GA. GGG T..
X81028H.manz' C G.G GT. AT. CC G.G C T.. G.A GA GGG T..
L12765"F.rcpni"
(XX) Hblis (IVS ranmedve) C G.G GT. AT, C.C G.G C T.. G.A GA GGG T..
136141 H.pJdlarm C G.G GT. AT. C.C G.G C T.. G.A GA GGG T..
u65103H trgognum C G.G GT. AT. C.C G.G C T.. G.A GA GGG T.
u07574H.hq-pcts C G.G GT. AT. C.C G.G CC T.. G.A GA GGG T.
AF058768H helmcni .C G.G GT. AT. C.C G.G CC T.. G.A GA. GGG T..
N6205H.nuidcrn C G.G GT. AT C.C G.G .C T.. G.A GA GGG T.
N8147 H.pcmasis C G.G GT. AT. C.C G.G .CC T.. GA GA. GGG T.
U96296H.rxnflu C G.G GT. AT. C.C G.G .C T. G.A GA. GGG T..
W5048H.mustdo C G.G GT. AT. C.C G.G .CC T. N.A GA. GGG T..
ABOD6148H.suncus C G.G GT. AT. C.C G.G .C T. GA GA GGG T.
NW59WdndlaSucncgnes C G.G GT. AT. C.C G.G .C T. GA GA. GGG T.
66% Hdicctxrats Ccncnsus C G.G GT. AT. C.C G.G .CC T. G.A GA. GGG T..
16s pAcri 289R PrIma(gard) 3' G CC CA TA GG CC GG A CT CT 0CC A 5'
U00006 E.cdi rrsB (universd) .C A. GGT GC T GC AT G G.C T G. TCG
m88157 H.p/ior (1) ..G A. AAA CA GGT GCT G.C AC. GGC
U00679 H.pyiori (2) ..G A. AAA CA GGT GCT G.C AC. GGC
Z25741 Hpyiori (3) ..G A. AAA CA GGT GCT G.C AC. GGC
M/55303 H.pyiori (4) ~~~ --- -~~ --- ~~- -~~ ~~~ ~~~ ~~~
X67854 H.nemetrino ..G A. AAA CA GGT GCT G.C AC. GGC
M37643 H.feis ..G A. AAA .CA GGT GCT G.C AC. GGC
u51872 H.feis ..G A. AAA .CA GGT GCT G.C AC. GGC
L13464 H.cnis ..G A. AAA .CA GGT GCT G.C AC. GGC
M8150 H.dnod ..G A. AAA .CA GGT GCT N.C AC. GGC
U46129 H.didoeCystus ..G A. AAA .CA GGT GCT G.C AC. GGC
Y09405 H.sdcrmcnis ..G A. AAA .CA GGT GCT G.C AC. GGC
X81028 H."manz" ..G A. AAA .CA GGT GCT G.C AC. GGC
L12765"F.rcp ni" ..G A. AAA CA GGT GCT G.C AC. GGC
(XX) Hblis (IVS reToveD) ..G A. ANA CA GGT GCT G.C AC. GGC
136141 H.pJllorum ..G A. AAA CA GGT GCT G.C AC. GGC
u65103 H.trogzntum ..G A. AAA CA GGT GCT G.C AC GGC
u07574 H.hepalias ..G A. AAA CA GGT GCT G.C AC GGC
AF058768 H.hdlmcnnii ..G A. AAA CA GGT GCT G.C AC. GGC
B0205 H.muridorum ..G A. AAA CA GGT GCT G.C AC GGC
M8147 H.paTiensis ..G A. AAA CA GGT GCT G.C AC GGC
U96296 H.roentium ..G A. AAA CA GGT GCT G.C AC GGC
M35048 H.mustdo ..G A.. AAA CA GGT GCT G.C AC. GGC
AB006148 H.suncus ..G A. AAA CA GGT GCT G.C AC. GGC
M8159 WdindlaSuodnogenes ..G A. AAA CA GGT GCT G.C AC GGC
66% Hdicbcdeas Concosus ..G A. AAA .CA GGT GCT G.C AC. GGC
16s p/ori 1026R Primer (genad) 3' C T TTT GT CA CGA CG TG CCG 5'
The primers are named according to the position of the 5' end of the primer in the H. pylori
sequence. The sites are predicted to lie on small stem loops on the rRNA. The corresponding sites on the
E. coli rRNA are as follows:
Helicobacter pylori specific primers:
787F 829->852
1017R 1054->1029
976F 1013->1041
1127R 1158->1135
Helicobacter genus primers:
212F 227->253
289R 304->283
1026R 1064->1045
15
